Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer
Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
News Release
Rogel research team receives $3. 2 M grant to cascade genetic testing to relatives
A team of researchers based at the University of Michigan Rogel Cancer Center and Stanford University received $3.2million from the National Cancer Institute for a clinical trial to help patients with a hereditary-based cancer diagnosis extend genetic testing to at-risk relatives.
Health Lab
Study explains how colorectal cancer cells maintain high iron levels
How colorectal cancer cells maintain high iron levels, according to Michigan Medicine research.
News Release
Ljungman receives $500K from the Little Warrior Foundation for Ewing sarcoma gene-editing therapy
Mats Ljungman, Ph.D., professor of radiation oncology and environmental health sciences at the University of Michigan, received a $528,728 award from the Little Warrior Foundation to further research using a gene editing system to target a gene fusion involved in Ewing sarcoma.
News Release
2 Rogel members recognized by American Thyroid Association
Megan R. Haymart, M.D., and Maria Papaleontioui, M.D., both received awards from the the American Thyroid Association.
Health Lab
Study sheds light on how early pancreas lesions become cancerous
Why many precursor lesions never develop into pancreatic cancer, according to findings from Michigan Medicine.
Health Lab
An online intervention can help cancer patients share genetic testing results with family
Katz and colleagues developed a web-based intervention to educate people with cancer about the impact genetic variants can have on their family.
News Release
Chinnaiyan receives International Harrington Prize
2026 Harrington Prize for Innovation in Medicine recognizes pioneering work in prostate cancer diagnosis and treatment
Health Lab
Diagnosed with pancreatic cancer: Now what?
A pancreas cancer surgeon explains from Michigan Medicine how to find the best place for treatment, why that matters, and what to expect from the process.
News Release
Can AI help predict outcomes in ovarian cancer?
International team of researchers awarded $2M grant to apply AI to identify factors tied to long term survival
News Release
Xu named among Time magazine’s most influential in health
U-M Health Rogel Cancer Center research member Zhen Xu, Ph.D., was selected to Time magazine’s TIME100 Health.
Health Lab
Expanding brain tumor research
Maria Castro, Ph.D, of Michigan Medicine, received a prestigious $4.5M NIH grant that will help advance the understanding about deadly tumors and provide a path for developing new treatments.
News Release
Rogel Cancer Center names Christopher Liekweg associate director for administration
The University of Michigan Rogel Cancer Center has named Christopher J. Liekweg, M.B.A., CMPE, associate director for administration and chief department administrator.
Liekweg is a senior administrator at VCU Health, the academic medical center of Virginia
News Release
Rogel Cancer Center adds 3 new senior leadership roles
The University of Michigan Rogel Cancer has named two new deputy directors and a new associate director to provide strategic leadership in cancer care, research and training: Michael Deininger, M.D., Ph.D.; Lesly Dossett, M.D., M.P.H.; and Samuel Kaffenberger, M.D.
Health Lab
How genetic testing impacts the whole family
Rogel Cancer Center researcher Steven J. Katz, M.D., M.P.H., on how genetic testing results impact both the cancer patient and their family.
Health Lab
Study shows how smoking drives pancreatic cancer
Why smokers have a higher chance of developing pancreatic cancer and why they tend to have worse outcomes than nonsmokers, according to a new study by University of Michigan Health Rogel Cancer Center.
